Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

TScan Therapeutics (TCRX) Other Gross PP&E Adjustments (2020 - 2025)

TScan Therapeutics (TCRX) has disclosed Other Gross PP&E Adjustments for 6 consecutive years, with -$29.8 million as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 25.71% to -$29.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$29.8 million through Dec 2025, up 25.71% year-over-year, with the annual reading at -$29.8 million for FY2025, 25.71% up from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was -$29.8 million at TScan Therapeutics, up from -$59.9 million in the prior quarter.
  • The five-year high for Other Gross PP&E Adjustments was $10.4 million in Q4 2021, with the low at -$63.5 million in Q1 2025.
  • Average Other Gross PP&E Adjustments over 5 years is -$37.8 million, with a median of -$42.3 million recorded in 2023.
  • The sharpest move saw Other Gross PP&E Adjustments soared 2856.82% in 2021, then plummeted 1180.1% in 2023.
  • Over 5 years, Other Gross PP&E Adjustments stood at $10.4 million in 2021, then crashed by 479.41% to -$39.5 million in 2022, then fell by 7.07% to -$42.3 million in 2023, then increased by 5.17% to -$40.1 million in 2024, then grew by 25.71% to -$29.8 million in 2025.
  • According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at -$29.8 million, -$59.9 million, and -$62.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.